Thermo Fisher Scientific Inc. (US), Danaher Corporation (US) and Merck KGaA (Germany) are Leading Players in the Cell Expansion Market
The cell expansion market is projected to reach USD 26.7 billion by 2029 from an estimated USD 14.3 billion in 2024, at a CAGR of 13.3% during the forecast period. The major factors driving the growth of this cell expansion market include growing need for cell and gene therapy, rising focus on personalized medicine, and increasing investments in cell-based research.
The global cell expansion market is competitive with top players such as Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), and Sartorius AG (Germany). The market players have adopted various strategies such as new product launches, acquisitions, agreements, collaborations, and geographical expansions to strengthen their position in the global cell expansion market.
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific Inc. (US)
Thermo Fisher Scientific Inc. is a leading science and technology company engaged in manufacturing high-end analytical instruments, laboratory equipment, software, consumables, reagents, and services for scientific research, analysis, discovery, and diagnostics. It focuses on acquiring new consumers through partnerships, collaborations, and expansions in emerging markets like China, India, and South Korea. The company further aims to strengthen its presence in selected geographies, undertaking various organic and inorganic growth strategies. For instance, in May 2023, the company has opened a new sterile drug facility in Singapore that will better enable customers to deliver new medicines and vaccines in the Asia-Pacific market.
Danaher Corporation (US)
Danaher Corporation is a leading life sciences and diagnostics innovator providing a wide range of products and services for medical, industrial, and commercial applications. With this strong global presence, Danaher Corporation is constantly involved in product innovations, which have increased the company’s overall revenue. The company continues to invest in research and development to provide innovative products. For instance, in 2022, the company’s research and development expenses were USD 1.75 billion.
Meck KGaA (Germany)
Merck is a leading provider of solutions and services for research, biotechnology and pharmaceutical drug development and production. The company has a strong global presence across North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The company is focusing on expansion of manufacturing facilities to strengthen its footprints across the globe. For instance, in June 2023, the company invested USD 75.8 million (€ 70 Million) to expand reagent manufacturing in China. Merck KGaA and the Nantong Economic and Technological Development Area (NETDA) signed the corresponding agreement in support of this expansion. The NETDA facility produces cell culture media for Life Science customers.
Related Reports:
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
